Back to search

Article

GSK-3484862 targets DNMT1 for degradation in cells

2022-11-04

Abstract excerpt

<h4>ABSTRACT</h4> Maintenance of genomic methylation patterns at DNA replication forks by DNMT1 is the key to faithful mitotic inheritance. DNMT1 is often overexpressed in cancer cells and the DNA hypomethylating agents azacytidine and decitabine are currently used in the treatment of hematologic malignancies. However, the toxicity of these cytidine analogs and their ineffectiveness in treating solid tumors have...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
71488f45-9a36-5321-9e3d-2b753ec28266
DOI
10.1101/2022.11.03.514954
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
GSK-3484862 targets DNMT1 for degradation in cellsDOI 10.1101/2022.11.03.514954
Select a neighboring publication to make it the new centre.